PAYC vs STRO · P/E 33, rev $1.88B vs rev $62.0M
Paycom Soft (PAYC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Paycom Soft (PAYC) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PAYC currently screens at market cap $13.06B and trailing P/E 33.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PAYC and STRO stock pages for the full models.
Not investment advice.